Echo Therapeutics, Inc. Dilutive Share Adjustment
Echo Therapeutics, Inc. reported Dilutive Share Adjustment of 17.26 million shares for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2016-11-16
- Echo Therapeutics, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2016-09-30 was 17.26M shares, a 55.13% increase year-over-year.
- Echo Therapeutics, Inc. weighted average number diluted shares outstanding adjustment for the quarter ending 2015-09-30 was 11.13M shares.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month |
|---|---|---|
| 2016-09-30 | 17.26M shares 10-Q · filed 2016-11-16 | 11.42M shares 10-Q · filed 2016-11-16 |
| 2015-09-30 | 11.13M shares 10-Q · filed 2016-11-16 | 11.27M shares 10-Q · filed 2016-11-16 |